Latuda Lurasidone Hydrochloride 40 MG Oral Tablet Latuda
1 INDICATIONS AND USAGE LATUDA is indicated for: Treatment of adult and adolescent patients (13 to 17 years) with schizophrenia [see Clinical Studies ( 14.1 )] . Monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies ( 14.2 )] . Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies ( 14.2 )] . LATUDA is an atypical antipsychotic indicated for the treatment of: Schizophrenia in adults and adolescents (13 to 17 years) ( 1 , 14.1 ) Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients (10 to 17 years) as monotherapy ( 1 , 14.2 ) Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults as adjunctive therapy with lithium or valproate ( 1 , 14.2 )
Sunovion Pharmaceuticals Inc.
ROUND WHITE L 40
Related Pills
lurasidone hydrochloride 80 MG Oral Tablet Latuda
Sunovion Pharmaceuticals Inc.
Lurasidone Hydrochloride 60 MG Oral Tablet Latuda
Sunovion Pharmaceuticals Inc.
latuda lurasidone hydrochloride tablet film coated
sunovion pharmaceuticals inc.
seroquel quetiapine fumarate tablet film coated
astrazeneca pharmaceuticals lp
metoprolol succinate 50 mg
Cipla USA Inc.
Paroxetine Hydrochloride 40 MG Oral Tablet Paxil
apotex corp
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING LATUDA tablets are white to off-white, round (20 mg or 40 mg), white to off-white, oblong (60 mg), pale green, oval (80 mg) or white to off-white, oval (120 mg) and identified with strength-specific one-sided debossing, “L20” (20 mg), “L40” (40 mg), “L80” (80 mg) or “L120” (120 mg). Tablets are supplied in the following strengths and package configurations ( Table 39 ). Table 39: Package Configuration for LATUDA Tablets Tablet Strength Package Configuration NDC Code 20 mg Bottles of 30 63402-302-30 Bottles of 90 63402-302-90 Bottles of 500 63402-302-50 Box of 100 (Hospital Unit Dose) 10 blister cards, 10 tablets each 63402-302-10 Carton 63402-302-01 Blister 40 mg Bottles of 30 63402-304-30 Bottles of 90 63402-304-90 Bottles of 500 63402-304-50 Box of 100 (Hospital Unit Dose) 10 blister cards, 10 tablets each 63402-304-10 Carton 63402-304-01 Blister 60 mg Bottles of 30 63402-306-30 Bottles of 90 63402-306-90 Bottles of 500 63402-306-50 Box of 100 (Hospital Unit Dose) 10 blister cards, 10 tablets each 63402-306-10 Carton 63402-306-01 Blister 80 mg Bottles of 30 63402-308-30 Bottles of 90 63402-308-90 Bottles of 500 63402-308-50 Box of 100 (Hospital Unit Dose) 10 blister cards, 10 tablets each 63402-308-10 Carton 63402-308-01 Blister 120 mg Bottles of 30 63402-312-30 Bottles of 90 63402-312-90 Bottles of 500 63402-312-50 Box of 100 (Hospital Unit Dose) 10 blister cards, 10 tablets each 63402-312-10 Carton 63402-312-01 Blister Storage Store LATUDA tablets at 25°C (77°F); excursions permitted to 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature] .
More pills like ROUND L 40